Angola vs Malaysia: The number of people with susceptibility test result for rifampicin
Angola
10,250
in 2021
Malaysia
10,434
in 2021
Angola rank
21st
Malaysia rank
20th
The number of people with susceptibility test result for rifampicin over time
- Angola
- Malaysia
How they compare
Malaysia currently reports 10,434 against 10,250 in Angola, a difference of 184.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Malaysia ahead.
Angola ranks 21st and Malaysia ranks 20th of 155 countries.
Malaysia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Angola | Malaysia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 9,969 | 11,620 | 1,651 | Malaysia |
| 2020s | 5,672 | 10,381 | 4,708 | Malaysia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Angola or Malaysia?
- Malaysia, at 10,434 against 10,250 in Angola as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Angola and Malaysia?
- 184, with Malaysia ahead.
- How many years of comparable data are there for Angola and Malaysia?
- 5 years are reported by both, from 2017 to 2021.
- How do Angola and Malaysia rank globally for the number of people with susceptibility test result for rifampicin?
- Angola ranks 21st and Malaysia ranks 20th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.